Design and development of a peptide-based adiponectin receptor agonist for cancer treatment
<p>Abstract</p> <p>Background</p> <p>Adiponectin, a fat tissue-derived adipokine, exhibits beneficial effects against insulin resistance, cardiovascular disease, inflammatory conditions, and cancer. Circulating adiponectin levels are decreased in obese individuals, and...
Main Authors: | Lovas Sandor, Kovalszky Ilona, Graziano Patrizia, Maspero Federica, La Russa Francesca, Haspinger Eva, Otvos Laszlo, Nama Kaushik, Hoffmann Ralf, Knappe Daniel, Cassone Marco, Wade John, Surmacz Eva |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | BMC Biotechnology |
Online Access: | http://www.biomedcentral.com/1472-6750/11/90 |
Similar Items
-
Development of second generation peptides modulating cellular adiponectin receptor responses
by: Laszlo eOtvos, et al.
Published: (2014-10-01) -
Potential Adiponectin Receptor Response Modifier Therapeutics
by: Laszlo Otvos, et al.
Published: (2019-08-01) -
Editorial: Adiponectin: Friend or Foe? Toward Understanding the Complexities of Adiponectin Biology and Challenges in Pharmaceutical Development
by: Eva Surmacz, et al.
Published: (2020-05-01) -
Glioblastoma-derived Leptin Induces Tube Formation and Growth of Endothelial Cells: Comparison with VEGF Effects
by: Otvos Laszlo, et al.
Published: (2011-07-01) -
Exploring leptin antagonism in ophthalmic cell models.
by: Laura Scolaro, et al.
Published: (2013-01-01)